Microwave Ablation System for Liver Tumors
Author Information
Author(s): Zhang Liang, Luerken Lukas, Mayr Vinzenz, Goetz Andrea, Schlitt Alexandra, Stroszczynski Christian, Einspieler Ingo, Minami Yasunori
Primary Institution: University Medical Center Regensburg
Hypothesis
The study aims to evaluate the efficacy and safety of the Surgnova Dophi™ M150E microwave ablation system in liver tumor treatment.
Conclusion
The Surgnova Dophi™ M150E system demonstrates excellent efficacy and safety for treating liver tumors.
Supporting Evidence
- Complete tumor eradication was achieved in 75 out of 77 tumors, resulting in a primary technique efficacy of 97.4%.
- Complications occurred in 10% of patients, with only 4% classified as major.
- The study confirmed the reliability of the system in achieving reproducible and predictable ablation results.
Takeaway
Doctors used a special microwave machine to treat liver tumors in 50 patients, and it worked really well with few problems.
Methodology
This was a prospective single-center observational study involving 50 patients with liver tumors who underwent CT-navigated stereotactic microwave ablation.
Potential Biases
The study lacks a comparison group with other microwave ablation systems, which may introduce bias in assessing relative efficacy.
Limitations
The study is limited by its single-center design and relatively small sample size, which may affect generalizability.
Participant Demographics
The cohort included 50 patients, with a mean age of 64.9 years, consisting of 37 males and 13 females.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website